Gene · 3093
UBE2K: ubiquitin conjugating enzyme E2 K
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. UBE2K: ubiquitin conjugating enzyme E2 K. Genes, record 3093. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3093
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P61086 | Ubiquitin-conjugating enzyme E2 K | 200 | 13 | Ensembl, GeneID, HGNC |
Source UniProt
Patents44
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1891 | P61086 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1891 | P61086 | Espacenet |
| JP 2025003968 A | 2025-01-14 | 1 | P61086 | Espacenet |
| JP 2023550743 A | 2023-12-05 | 84 | P61086 | Espacenet |
| JP 2023504790 A | 2023-02-07 | 16 | P61086 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 4895 | P61086 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 95238 | P61086 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 198209 | P61086 | Espacenet |
| JP 2022500378 A | 2022-01-04 | 2 | P61086 | Espacenet |
| JP 2021525807 A | 2021-09-27 | 12 | P61086 | Espacenet |
1 to 10 of 44
See all 44 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,613
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | UBE2K papers | Newest fiscal year |
|---|---|---|---|
| R01GM065334 | Solution structure and dynamics of polyubiquitin chains | 14 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 11 | 2025 |
| R01HD059205 | Interventions in math learning disabilities: cognitive and neural correlates | 10 | 2025 |
| R01ES012512 | Roles of Lig3 and XRCC1 Genes in Genome Stability | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA118100 | University of New Mexico Cancer Center Support Grant | 6 | 2025 |
| P20GM103440 | Nevada IDeA Networks of Biomedical Research Excellence (INBRE) | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 3 | 2025 |
1 to 10 of 1,613Source NIH's project files
See all 1,613 nih grantsPapers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7. | Sci Rep | 2026 | 42744935 | PubTator, text mining | PubMed |
| [Ubiquitination-mediated regulation of T cell homeostasis and autoimmune diseases]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | 42702386 | PubTator, text mining | PubMed |
| Disruption of the ubiquitin-mediated proteolysis pathway: a study of seed aging in Saposhnikovia divaricata caused by UBC1 gene family suppression. | BMC Plant Biol | 2026 | 42337438 | PubTator, text mining | PubMed |
| Porcine Reproductive and Respiratory Syndrome Virus NSP8 Suppresses NF-κB Signaling by Hijacking Host UBE2K and IKKα. | Viruses | 2026 | 42198770 | PubTator, text mining | PubMed |
| SNRPD2-CPSF7-UBE2K axis drives ovarian cancer progression via alternative splicing-polyadenylation crosstalk. | Oncogene | 2026 | 42098443 | PubTator, text mining | PubMed |
| CXCR4 coordinates adhesion, migration, and development of human NK cells. | bioRxiv | 2026 | 42051299 | PubTator, text mining | PubMed |
| Insight into the potential significance of miR-760 and miR-1973 in breast cancer: a comprehensive analysis. | Sci Rep | 2026 | 41922567 | PubTator, text mining | PubMed |
| North American ice sheet persistence into past interglacials should inform future projections. | Nat Commun | 2026 | 41792116 | PubTator, text mining | PubMed |
| Dual targeting of the UPS and autophagy as a novel therapy for neurodegenerative proteinopathies. | Front Cell Neurosci | 2026 | 41788195 | PubTator, text mining | PubMed |
| Combining Laser-Induced Graphene with Kirigami for Transparent Flexible Electromagnetic Interference Shielding. | ACS Appl Eng Mater | 2026 | 41783240 | PubTator, text mining | PubMed |
1 to 10 of 3,161
See all 3,161 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3093
GET https://conductscience.org/api/genes/v1/3093/patents?page=2